These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9510206)

  • 1. Functional differences among multiple isoforms of guinea pig decay-accelerating factor.
    Wang G; Nonaka M; He C; Okada N; Nakashima I; Okada H
    J Immunol; 1998 Mar; 160(6):3014-22. PubMed ID: 9510206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
    Iwata K; Seya T; Ariga H; Nagasawa S
    J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple isoforms of guinea pig decay-accelerating factor (DAF) generated by alternative splicing.
    Nonaka M; Miwa T; Okada N; Nonaka M; Okada H
    J Immunol; 1995 Sep; 155(6):3037-48. PubMed ID: 7545710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decay-accelerating factor in the periovulatory rat ovary.
    Gieske MC; Na GY; Koo Y; Jo M; Curry TE; Ko C
    J Endocrinol; 2005 Aug; 186(2):303-13. PubMed ID: 16079256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of mouse DAF on transfectant cells using monoclonal antibodies which recognize different epitopes.
    Ohta R; Imai M; Fukuoka Y; Miwa T; Okada N; Okada H
    Microbiol Immunol; 1999; 43(11):1045-56. PubMed ID: 10609614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor.
    Brodbeck WG; Liu D; Sperry J; Mold C; Medof ME
    J Immunol; 1996 Apr; 156(7):2528-33. PubMed ID: 8786315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning and functional characterization of the rat analogue of human decay-accelerating factor (CD55).
    Hinchliffe SJ; Spiller OB; Rushmere NK; Morgan BP
    J Immunol; 1998 Nov; 161(10):5695-703. PubMed ID: 9820551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and functional analysis of mouse decay accelerating factor (CD55).
    Harris CL; Rushmere NK; Morgan BP
    Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):821-9. PubMed ID: 10417349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse decay-accelerating factor: selective and tissue-specific induction by estrogen of the gene encoding the glycosylphosphatidylinositol-anchored form.
    Song WC; Deng C; Raszmann K; Moore R; Newbold R; McLachlan JA; Negishi M
    J Immunol; 1996 Nov; 157(9):4166-72. PubMed ID: 8892654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tandem forms of DAF(CD55) on complement-mediated xenogeneic cell lysis.
    Miyagawa S; Fukuta D; Kitano E; Kobayashi C; Fumimoto Y; Shirasu A; Hattori H; Shirakura R; Fukuzawa M
    Xenotransplantation; 2006 Sep; 13(5):433-9. PubMed ID: 16925667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human recombinant soluble decay accelerating factor inhibits complement activation in vitro and in vivo.
    Moran P; Beasley H; Gorrell A; Martin E; Gribling P; Fuchs H; Gillett N; Burton LE; Caras IW
    J Immunol; 1992 Sep; 149(5):1736-43. PubMed ID: 1380537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning and characterization of novel splicing variants of human decay-accelerating factor.
    Osuka F; Endo Y; Higuchi M; Suzuki H; Shio Y; Fujiu K; Kanno R; Oishi A; Terashima M; Fujita T; Gotoh M
    Genomics; 2006 Sep; 88(3):316-22. PubMed ID: 16503113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pigs express multiple forms of decay-accelerating factor (CD55), all of which contain only three short consensus repeats.
    Pérez de la Lastra JM; Harris CL; Hinchliffe SJ; Holt DS; Rushmere NK; Morgan BP
    J Immunol; 2000 Sep; 165(5):2563-73. PubMed ID: 10946283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
    Lublin DM; Coyne KE
    J Exp Med; 1991 Jul; 174(1):35-44. PubMed ID: 1711565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative exon usage in the 3' region of a single gene generates glycosylphosphatidylinositol-anchored and transmembrane forms of rat decay-accelerating factor.
    Miwa T; Okada N; Okada H
    Immunogenetics; 2000 Feb; 51(2):129-37. PubMed ID: 10663575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential human serum-mediated neutralization of PERV released from pig cells transfected with variants of hDAF.
    Okura E; Ishimaru A; Yamamoto A; Nakatsu S; Shirakura R; Okabe M; Sawa Y; Fukuzawa M; Okumura M; Miyagawa S
    Xenotransplantation; 2008; 15(6):365-73. PubMed ID: 19152664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decay-accelerating factor (DAF/CD55) is a functional active element of the LPS receptor complex.
    Heine H; Ulmer AJ; El-Samalouti VT; Lentschat A; Hamann L
    J Endotoxin Res; 2001; 7(3):227-31. PubMed ID: 11581575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic pigs expressing human decay-accelerating factor regulated by porcine MCP gene promoter.
    Murakami H; Nagashima H; Takahagi Y; Miyagawa S; Fujimura T; Toyomura K; Nakai R; Yamada M; Kurihara T; Shigehisa T; Okabe M; Seya T; Shirakura R; Kinoshita T
    Mol Reprod Dev; 2002 Mar; 61(3):302-11. PubMed ID: 11835575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of decay-accelerating factor isoforms in the digestive tract of guinea pig.
    Mizoshita T; Joh T; Oshima T; Yamada T; Ohara H; Nomura T; Okada N; Itoh M
    Life Sci; 2002 Jan; 70(8):867-76. PubMed ID: 11853224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane cofactor protein (CD46) protects cells predominantly from alternative complement pathway-mediated C3-fragment deposition and cytolysis.
    Kojima A; Iwata K; Seya T; Matsumoto M; Ariga H; Atkinson JP; Nagasawa S
    J Immunol; 1993 Aug; 151(3):1519-27. PubMed ID: 8335944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.